Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and 69 years of age received a prostate-specific antigen (PSA) test. Localized prostate cancer was diagnosed in 2664 men. Of these ...
Telomerase Is a Prognostic Marker of Poor Outcome and a Therapeutic Target in Neuroblastoma Despite decreased screening-based detection of clinically insignificant tumors, most diagnosed prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results